medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2001, Number 2

<< Back Next >>

Gac Med Mex 2001; 137 (2)

Neuroendocrine Pancreatic Tumor

Gerson R, Serrano OA, Ortiz-Hidalgo C, Gómez-Palacio SM, Villalobos PA
Full text How to cite this article

Language: Spanish
References: 16
Page: 147-150
PDF size: 94.85 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Kroser JA, Metz DC. Evaluation of the adult patient with diarrhea. Primary Care 1996;23:1-13.

  2. Eriksson B, Oberg K, Alm G, et al. Treatment of malignant endocrine pancreatic tumors with human leucocyte interferon. Lancet 1986;2:1307-9.

  3. Friessen SR. Tumors of the endocrine pancreas. N Engl J Med 1982;306:580-90.

  4. Namihira Y, Achord JL, Subramony C. Multiple endocrine neoplasia, type 1, with pancreatic cholera. Am J Gastroenterol 1987;82:794-7.

  5. Editorial. VIP ands diarrhoea. Lancet 1984;1:202.

  6. Clements D, Elias E. Regression of metastatic vipoma with somatostain analogue SMS 201'995.Lancet 1985;1:874:5.

  7. Udall JN Jr. Secretory diarrhea in children .Pediatric Clinic North Am 1996;43:333-52.

  8. Fraker DL, Jensen RT. Pancreatic endocrine tumors. In De Vita VT, Hellman S, Rosemberg SA. Cancer: principles and practice of oncology. Philadelphia, USA. Lippincot-Raven, 5a ed. 1997. p. 1678-1703.

  9. Bloom SR, Christofides ND, Delamarter J, et al. Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (Peptide histidine isoleucine) explained by single coding gene. Lancet 1983;2:1163-5.

  10. Brunt LM, Mazoujian G, O´Dorisio TM et al. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome. Surgery 1994;115:362-9.

  11. Polak JM. Bloom SR, Adrain TE, et al. Pancreatic polypeptide in insulinomas, gastrinomas, vipomas and glucoganomas. Lancet 1976;1:328-30.

  12. Cavallo-Perin P, De Paoll M, Guiso G, et al. A combined glucagonoma and VIPoma syndrome. First pathologic report. Cancer 1988;62:2576-9.

  13. Wynick D, Williams SJ, Bloom SR. Symptomatic secundary hormone syndromes in patients with established malignant pancreatic endocrine tumors. N Engl J Med 1988; 319:605-7.

  14. Rambaud JC, Nisard A, Modigliani R, et al. Hypercalcitoninemia in vipomas. Lancet 1978;1:220.

  15. Cellier C, Yaghi C, Cuilleier E, et al Metastatic jejunal VIPoma: beneficial effect of combination therapy with interferon-alpha and 5-fluorouracil. Am J Gastroenterol 2000;95:289-93.

  16. Nagorney DM, Bloom SR, Polak JM, et al. Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma. Surgery 1983;93:348-53.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2001;137